# ENTECAVIR
> **ANDA212126** · Abbreviated New Drug Application (Generic) · Sponsor: BRIGHTGENE · Approved 2019-09-25
## Drug
- **FDA Application Number:** ANDA212126
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ENTECAVIR
- **Generic name:** ENTECAVIR
- **Active ingredients:** ENTECAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRIGHTGENE
- **Manufacturer:** EPIC PHARMA, LLC
- **First approval:** 2019-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212126)
---
*MORVS · CC0 1.0*